Tricuspid Valve Insufficiency clinical trials at UCSF

2 in progress, 1 open to eligible people

Tricuspid valve insufficiency is when the heart's valve doesn't close tightly, causing blood to leak backwards. UCSF is researching whether the Edwards PASCAL system can successfully fix this condition in patients with severe symptoms. These trials explore the safety and effectiveness of this heart repair method.

Showing trials for

  • Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial

    open to eligible people ages 18 years and up

    To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Repair System in patients with symptomatic severe tricuspid regurgitation who have been determined to be at an intermediate or greater estimated risk of mortality with tricuspid valve surgery by the cardiac surgeon with concurrence by the local Heart Team

    San Francisco, California and other locations

  • TRISCEND II Pivotal Trial

    Sorry, in progress, not accepting new patients

    Pivotal trial to evaluate the safety and effectiveness of the Edwards EVOQUE tricuspid valve replacement system

    San Francisco, California and other locations

Our lead scientists for Tricuspid Valve Insufficiency research studies include .

Last updated: